Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots 

Dana-Farber researcher Charles Stiles, PhD, remembers the call. It was 2008 and a colleague phoned from a conference to deliver the news. Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma. The problem of finding a genetic target to improve treatment for this … Read more

From Pediatric Cancer Treatment to Capitol Hill

Washington, D.C., can be a frenzied place, especially for a college student juggling a full class load and congressional internships on Capitol Hill. Jen Fox, however, is taking it all in stride. How does she stay so calm? Well, Fox suggests, two bouts with Hodgkin lymphoma in three years, and a stem cell transplant at … Read more

Patrice Kelly’s Journey from Jimmy Fund Clinic Mom to Breast Cancer Patient

Charlotte Kelly hated having her chemotherapy port accessed, but her mother, Patrice, found a way to calm the toddler. Each time tears came, Patrice would rub her nose against Charlotte’s – and the pair would get past their fears together. Today the ritual continues, even though Charlotte’s last neuroblastoma checkup at Dana-Farber/Boston Children’s Cancer and … Read more

Voices Podcast – Season 2 Episode #4: Then and Now with Neuroblastoma Patient Emily Coughlin

Amy McHugh’s 4-year-old daughter, Emily Coughlin, was a typical kid – playful and inquisitive – until May 2009, when she started complaining of knee pain. After a visit to the pediatrician, and a misdiagnosis of Lyme disease, the family ended up at Boston Children’s Hospital, where they received a devastating diagnosis: Emily had high-risk neuroblastoma, … Read more

What’s New in Pediatric Brain Tumor Research and Care?

Mark W. Kieran, MD, PhD, director of Pediatric Medical Neuro-Oncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, spoke to pediatric patient families in a recent Facebook Live Webchat addressing pediatric brain tumor care. Kieran answered questions from audience members about the most common of the 300 brain tumor types that occur in children, including … Read more

Facing Fertility Issues as a Pediatric Cancer Survivor

In her research studies with young adult survivors of childhood cancers, pediatric oncologist Natasha Frederick, MD, MPH, of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, explored sexual dysfunction in survivors between the ages of 18 and 30 years old. She found that most of these young survivors reporting such problems keep their concerns from partners, loved ones, and caregivers, and … Read more

How Pediatric and Canine Cancer Similarities Can Help Both Children and Pets

In March 2016, Ollie the pug, a therapy dog at Boston Children’s Hospital, paid a bedside visit to 7-year-old Carter Mock. Both dog and boy lost limbs to osteosarcoma, a cancer of the bone. Ollie’s left front leg was amputated at the shoulder. After removing the tumor in Carter’s left leg bone, surgeons fashioned  a … Read more

He Lost His Sight to Cancer, But Not His Vision of a Full Life

When Tim Conners collected his wish from the Make-A-Wish Foundation in 2012 at the age of 18, he was blind from childhood leukemia that had spread to his optic nerve. A football player and wrestler who’d never been an outdoorsman, he asked to meet Erik Weihenmayer, the first blind person to climb the Seven Summits … Read more

Finding Strength and Beauty During Annual ‘Girls Weekend’

For seventeen girls and patients at Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Dana-Farber’s annual Girls Weekend – a three-day arts, shopping, and food extravaganza – is a much-needed opportunity to relax and connect with new friends who also know what it’s like to have cancer. “Being a teenager – especially when you’re a … Read more

Lymphoma Patient Gets Back on the Court Post-Treatment

For much of his 17 years, Spencer Riley has lived to play basketball. This winter, his favorite sport helped the teenager get back to life. Riley was diagnosed with non-Hodgkin lymphoma in 2016 and treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center that summer. He underwent an intensive three-month treatment cycle: one week of … Read more

Improving Childhood Cancer Treatment Worldwide [Infographic]

Cancer knows no borders, and pediatric patients in low- and middle-income countries often have less access to quality care. The Global Health Initiative at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center exists to change this by improving outcomes and survival rates for children with cancer and blood disorders, regardless of their place of birth. View … Read more

The Loss of a Child: Stories from Three Bereaved Parents

As told to Sue Morris, PsyD As director of Dana-Farber’s Bereavement Program, I regularly sit with bereaved individuals, listen to their stories, and help them navigate their lives after they have been completely turned upside down. I recently spoke with three bereaved parents who are members of Dana-Farber’s Pediatric Patient and Family Advisory Committee (PFAC), … Read more